High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group (Q70705675)
Jump to navigation
Jump to search
scientific article published on 01 June 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group |
scientific article published on 01 June 1993 |
Statements
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group (English)
S N Wolff
J W Fay
R H Herzig
J P Greer
S Dummer
R A Brown
R H Collins
D A Stevens